Post-approval studies (Phase 4)Study completedNCT00672139
What this trial is testing
Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness
Who this might be right for
Opioid-Induced Constipation
Bausch Health Americas, Inc. 156